Bullish Moving Averages
5
Bearish Moving Averages
11
Back Stocks profile
Stock analysis tool for investors
Open an Account with Bigul in 5 minutes
Performance
Today’s low
102.90Today’s High
105.2052W low
75.4052W High
149.60Open Price
103.80Prev. Close
101.0500Volume
243014.00Value
25110636.62Fundamentals
Market Cap Cr
1083.80
Price to Earnings
14.40
Price to Book Value
1.10
Dividend Yield
0.50
PE to Growth
2.20
Op Revenue TTM Cr
770.24
Net Profit TTM Cr
75.45
Cash From Operating Activity Cr
152.45
Return on Equity %
7.80
EMA & SMA
DELIVERY AND VOLUME
DAILY AVG. DELIVERY VOLUME %
02 Jul, 2024
45.5
Week
51.1
Month
47.7
LEGEND
Positive Indicator
Neutral Indicator
Negative Indicator
RESISTANCE AND SUPPORT
104.26
PIVOT
First Resistance
105.33
Second Resistance
106.82
Third Resistance
107.89
First Support
102.77
Second Support
101.70
Third Support
100.21
Relative Strength Index
47.63
Money Flow Index
52.61
MACD
-1.21
MACD Signal
-1.48
Average True Range
3.27
Average Directional Index
21.35
Rate of Change (21)
0.9
Rate of Change (125)
-16.7
Commodity Channel Index
34.3
Williams %R
-61.8
BETA
1 Month
0.52
3 Month
0.58
1 Year
0.78
3 Year
0.32
PRICE CHANGE ANALYSIS
↓ -0.15%
1 Week
Low
High
101.01
105.76
↑ 0.42%
1 Month
Low
High
92.15
108.4
↓ -12.51%
3 Months
Low
High
92.15
131
↓ -22.89%
6 Months
Low
High
92.15
142.4
↑ 28.76%
1 Year
Low
High
75.45
149.6
| Indicator | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Graph |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Qtr Revenue cr | 172.28 | 169.23 | 181.93 | 115.52 | 149.90 | 180.21 | 153.08 | 165.91 | 150.74 | 196.91 | 180.41 | |
| Operating Expenses Qtr | 138.67 | 132.67 | 129.01 | 97.94 | 132.51 | 135.33 | 112.21 | 128.13 | 129.26 | 158.77 | 141.66 | |
| Operating Profit Qtr | 25.15 | 28.66 | 42.31 | 11.05 | 10.91 | 33.46 | 26.64 | 19.15 | 9.05 | 31.82 | 32.76 | |
| EBIDT Qtr Cr | -7.47 | 36.56 | 52.92 | 17.58 | 17.39 | 44.88 | 40.87 | 37.78 | 21.48 | 40.88 | 38.75 | |
| Depreciation Qtr | 6.23 | 6.25 | 5.68 | 5.36 | 3.97 | 3.79 | 3.73 | 3.67 | 3.41 | 3.51 | 3.45 | |
| Net Profit Qtr | -11.46 | 20.72 | 33.89 | 7.50 | 6.11 | 29.28 | 25.45 | 24.65 | 9.47 | 27.17 | 24.73 | |
| Basic EPS Qtr | -1.11 | 1.99 | 3.25 | 0.72 | 0.60 | 2.81 | 2.45 | 2.38 | 1.85 | 2.62 | 2.39 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total Revenue Annual | 638.96 | 649.11 | 668.98 | 483.20 | 478.95 | |
| Operating Expenses Annual Cr | 498.29 | 508.18 | 527.16 | 374.05 | 341.78 | |
| Operating Profit Annual | 107.17 | 90.16 | 109.20 | 91.46 | 100.17 | |
| Operating Profit Margin Annual % | 16.77 | 13.89 | 16.32 | 18.93 | 20.91 | |
| Total Expenses Annual Cr | 527.62 | 533.41 | 545.33 | 392.01 | 357.24 | |
| EBIDT Annual Cr | 140.67 | 140.92 | 141.83 | 109.14 | 137.17 | |
| EBIDT Annual margin % | 22.02 | 21.71 | 21.20 | 22.59 | 28.64 | |
| Depreciation | 23.52 | 15.17 | 13.85 | 13.76 | 8.83 | |
| PAT Before ExtraOrdinary Items Annual Cr | 50.64 | 85.48 | 92.66 | 67.50 | 92.33 | |
| Net Profit Annual | 50.64 | 85.48 | 92.66 | 67.50 | 92.33 | |
| Basic EPS Annual | 4.85 | 8.23 | 8.97 | 6.54 | 8.95 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total ShareHolders Funds Annual | 988.44 | 937.00 | 851.43 | 755.65 | 682.94 | |
| Minority Interest Liability Annual Cr | - | - | - | - | - | |
| Total Non Current Liabilities Annual Cr | 46.80 | 49.34 | 35.71 | 43.87 | 46.59 | |
| Total Current Liabilities Annual Cr | 117.31 | 153.36 | 192.83 | 146.11 | 125.56 | |
| Total Capital Plus Liabilities Annual Cr | 1152.55 | 1139.69 | 1079.96 | 945.62 | 855.10 | |
| Fixed Assets Annual | 338.47 | 328.30 | 247.16 | 177.18 | 179.55 | |
| Total Non Current Assets Annual | 379.57 | 410.04 | 289.05 | 268.98 | 211.05 | |
| Total Current Assets Annual | 772.98 | 729.65 | 790.92 | 676.64 | 644.05 | |
| Total Assets Annual | 1152.55 | 1139.69 | 1079.96 | 945.62 | 855.10 | |
| Contingent Liabilities plus Commitments Annual Cr | - | 10.09 | 21.81 | 30.06 | 14.33 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Cash from Operating Activity Annual | 125.92 | 43.81 | 114.05 | 66.97 | 58.03 | |
| Cash from Investing Activity Annual | -109.59 | -12.97 | -92.28 | -61.62 | -57.89 | |
| Cash from Financing Annual Activity | -20.76 | -26.05 | -12.62 | -11.67 | -2.86 | |
| Net Cash Flow Annual | - | 4.79 | 9.14 | -6.33 | -2.72 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Book Value Per Share Annual | 94.42 | 89.96 | 82.12 | 73.26 | 66.21 | |
| ROE Annual % | 5.12 | 9.12 | 10.88 | 8.93 | 13.52 | |
| ROCE Annual % | 11.31 | 12.74 | 14.42 | 11.92 | 17.59 | |
| Total Debt to Total Equity Annual | 0.07 | 0.08 | 0.10 | 0.09 | 0.10 | |
| EBDIT Annual Margin % | 23.23 | 23.55 | 22.28 | 23.44 | 31.03 |
| Indicator | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Graph |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Qtr Revenue cr | 203.73 | 206.14 | 224.48 | 164.63 | 187.76 | 211.36 | 174.58 | 195.67 | 179.25 | 222.29 | 201.44 | |
| Operating Expenses Qtr | 169.78 | 157.02 | 157.51 | 135.31 | 178.54 | 158.03 | 147.88 | 149.81 | 146.90 | 182.09 | 166.58 | |
| Operating Profit Qtr | 28.35 | 43.69 | 54.37 | 24.21 | 6.24 | 47.69 | 24.55 | 38.85 | 20.17 | 34.17 | 29.41 | |
| EBIDT Qtr Cr | 4.75 | 49.12 | 66.97 | 29.33 | 9.22 | 53.33 | 26.70 | 45.86 | 32.35 | -33.39 | 34.86 | |
| Depreciation Qtr | 6.85 | 6.95 | 6.39 | 6.19 | 4.88 | 4.64 | 4.60 | 4.55 | 4.27 | 4.43 | 4.30 | |
| Net Profit Qtr | -9.15 | 27.61 | 42.31 | 14.69 | 3.34 | 27.94 | 13.85 | 25.72 | 19.63 | -50.11 | 21.27 | |
| Basic EPS Qtr | -0.88 | 2.64 | 4.06 | 1.41 | 0.34 | 2.68 | 1.33 | 2.48 | 1.90 | -4.83 | 2.05 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total Revenue Annual | 798.98 | 769.37 | 778.95 | 597.43 | 728.49 | |
| Operating Expenses Annual Cr | 619.62 | 634.26 | 629.11 | 470.56 | 565.99 | |
| Operating Profit Annual | 150.62 | 117.32 | 118.34 | 106.65 | 123.32 | |
| Operating Profit Margin Annual % | 18.85 | 15.25 | 15.19 | 17.85 | 16.93 | |
| Total Expenses Annual Cr | 652.91 | 663.30 | 651.19 | 493.30 | 586.15 | |
| EBIDT Annual Cr | 179.36 | 135.11 | 149.83 | 126.87 | 162.50 | |
| EBIDT Annual margin % | 22.45 | 17.56 | 19.24 | 21.24 | 22.31 | |
| Depreciation | 26.38 | 18.67 | 17.33 | 17.23 | 12.59 | |
| PAT Before ExtraOrdinary Items Annual Cr | 81.58 | 76.73 | 23.13 | 73.97 | 95.25 | |
| Net Profit Annual | 75.45 | 70.86 | 15.04 | 68.49 | 97.27 | |
| Basic EPS Annual | 7.23 | 6.72 | 1.43 | 6.49 | 9.43 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total ShareHolders Funds Annual | 967.19 | 883.90 | 818.70 | 808.25 | 735.61 | |
| Minority Interest Liability Annual Cr | 35.79 | 33.53 | 27.76 | 19.66 | 14.76 | |
| Total Non Current Liabilities Annual Cr | 51.06 | 46.17 | 29.20 | 45.24 | 46.47 | |
| Total Current Liabilities Annual Cr | 159.82 | 193.26 | 233.09 | 203.64 | 232.18 | |
| Total Capital Plus Liabilities Annual Cr | 1213.87 | 1156.85 | 1108.75 | 1076.79 | 1029.02 | |
| Fixed Assets Annual | 370.17 | 373.83 | 295.89 | 229.09 | 233.95 | |
| Total Non Current Assets Annual | 402.25 | 459.49 | 332.71 | 311.59 | 256.07 | |
| Total Current Assets Annual | 811.62 | 697.37 | 776.03 | 765.20 | 772.95 | |
| Total Assets Annual | 1213.87 | 1156.85 | 1108.75 | 1076.79 | 1029.02 | |
| Contingent Liabilities plus Commitments Annual Cr | - | 11.59 | 22.70 | 30.31 | 14.33 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Cash from Operating Activity Annual | 152.45 | 34.31 | 135.48 | 63.97 | 45.28 | |
| Cash from Investing Activity Annual | -132.82 | -7.75 | -92.98 | -46.99 | -48.95 | |
| Cash from Financing Annual Activity | -20.89 | -24.94 | -23.73 | -20.80 | -3.83 | |
| Net Cash Flow Annual | - | 1.62 | 18.78 | -3.82 | -7.50 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Book Value Per Share Annual | 95.80 | 88.08 | 81.64 | 80.27 | 72.75 | |
| ROE Annual % | 7.80 | 8.01 | 1.83 | 8.47 | 13.22 | |
| ROCE Annual % | 14.51 | 12.08 | 15.13 | 12.55 | 18.81 | |
| Total Debt to Total Equity Annual | 0.09 | 0.11 | 0.13 | 0.12 | 0.14 | |
| EBDIT Annual Margin % | 23.28 | 17.97 | 20.04 | 21.98 | 23.57 |
| Name | Holding Percent | Holding Id | Pledged % | Locked % |
|---|---|---|---|---|
| Polus Global Fund | 1.78 | 74798707 | - | - |
| Aspire Emerging Fund | 2.33 | 74798710 | - | - |
| Name | Holding Percent | Holding Id | Pledged % | Locked % |
|---|---|---|---|---|
| Narsimha Shibroor Kamath | 30.53 | 74798694 | 0 | 0 |
| Vibha Gagan Sharma | 2.36 | 74798695 | 0 | 0 |
| Shruti Vishal Rao | 2.02 | 74798696 | 0 | 0 |
| Name | Holding Percent | Holding Id |
|---|---|---|
| Arian Investment Limited | 9.42 | 74798709 |
| Aspire Emerging Fund | 2.33 | 74798710 |
| Polus Global Fund | 1.78 | 74798707 |
| Life Insurance Corporation Of India | 6.59 | 74798705 |
| Name | Holding Percent | Holding Id |
|---|---|---|
| Arjun Gautam Ashra . | 4.82 | 74798719 |
| Gautam Rasiklal Ashra | 2.81 | 74798720 |
| HUF | 1 | 74798712 |
| Gulbarga Trading And Investment Private | 5.58 | 74798716 |
| Investor Education And Protection Fund Authority Ministry Of Corporate Affairs | 2.39 | 74798725 |
| Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| Jul 12, 2023 | 0.5 | FINAL | - | Equity Share |
| Jun 20, 2022 | 0.5 | FINAL | - | Equity Share |
| Sep 13, 2021 | 0.5 | FINAL | - | Equity Share |
| Sep 17, 2020 | 0.5 | FINAL | - | Equity Share |
| Sep 12, 2019 | 1 | FINAL | - | Equity Share |
| Aug 14, 2018 | 1 | FINAL | - | Equity Share |
| Sep 18, 2017 | 0.6 | FINAL | - | Equity Share |
| Sep 06, 2016 | 0.5 | FINAL | - | Equity Share |
| Sep 08, 2015 | 0.5 | FINAL | - | Equity Share |
| Feb 24, 2015 | 0.2 | INTERIM | Feb 25, 2015 | Equity Share |
| Aug 13, 2014 | 0.5 | FINAL | - | Equity Share |
| Aug 01, 2013 | 0.4 | FINAL | - | Equity Share |
| Feb 25, 2013 | 0.3 | INTERIM | Feb 26, 2013 | Equity Share |
| Aug 02, 2012 | 0.4 | FINAL | - | Equity Share |
| Nov 24, 2011 | 0.35 | INTERIM | Nov 25, 2011 | Equity Share |
| Jul 14, 2011 | 0.3 | FINAL | - | Equity Share |
| Nov 25, 2010 | 0.3 | INTERIM | Nov 27, 2010 | Equity Share |
| Jul 22, 2010 | 0.5 | FINAL | - | Equity Share |
| Aug 13, 2009 | 0.15 | FINAL | - | Equity Share |
| May 14, 2008 | 0.1 | INTERIM | May 15, 2008 | Equity Share |
| Sep 13, 2007 | 1 | FINAL | - | Equity Share |
| Aug 10, 2006 | 1 | FINAL | - | Equity Share |
| Sep 09, 2004 | 1 | FINAL | - | Equity Share |
| Sep 04, 2003 | 1 | FINAL | - | Equity Share |
| Aug 28, 2002 | - | FINAL | - | Equity Share |
| Aug 17, 2001 | - | FINAL | - | Equity Share |
| Ex-Date | Split Ratio | Record Date |
|---|---|---|
| Mar 11, 2008 | 10:1 | 2008-03-18 |
| Ex-Date | Purpose | Notes |
|---|---|---|
| May 02, 2024 | Audited Results & Final Dividend | - |
| Jan 23, 2024 | Quarterly Results | - |
| Nov 01, 2023 | Quarterly Results | - |
| Aug 01, 2023 | Quarterly Results | - |
| May 11, 2023 | Audited Results & Final Dividend | - |
| Jan 24, 2023 | Quarterly Results | - |
| Nov 07, 2022 | Quarterly Results | - |
| Aug 03, 2022 | Quarterly Results | - |
| Apr 30, 2022 | Audited Results & Final Dividend | - |
| Jan 29, 2022 | Quarterly Results | - |
| Oct 30, 2021 | Quarterly Results | - |
| Jul 31, 2021 | Quarterly Results | - |
| May 11, 2021 | Audited Results & Final Dividend | - |
| Jan 21, 2021 | Quarterly Results | - |
| Oct 21, 2020 | Quarterly Results | - |
| Aug 20, 2020 | Quarterly Results | - |
| Jun 16, 2020 | Audited Results & Dividend | - |
| Feb 11, 2020 | Quarterly Results | - |
| Nov 11, 2019 | Quarterly Results | - |
| Aug 12, 2019 | Quarterly Results | - |
| May 18, 2019 | Audited Results & Dividend | - |
| Feb 25, 2019 | Employees Stock Option Plan | - |
| Jan 29, 2019 | Quarterly Results & ESOP | - |
| Nov 02, 2018 | Quarterly Results | - |
| Aug 09, 2018 | Quarterly Results | - |
| May 17, 2018 | Audited Results & Dividend | - |
| Jan 19, 2018 | Quarterly Results | - |
| Jan 11, 2018 | Others | To consider disinvestment of subsidiary business. |
| Nov 30, 2017 | Quarterly Results | - |
| Sep 06, 2017 | Quarterly Results | - |
| May 16, 2017 | Audited Results & Dividend | - |
| Feb 09, 2017 | Quarterly Results | - |
| Oct 26, 2016 | Quarterly Results | - |
| Jul 27, 2016 | Quarterly Results | - |
| May 24, 2016 | Audited Results & Final Dividend | 1. Accepted the resignation of Mr. Hira Sadhak an Independent Director with effect from May 17, 2016. 2. Appointed of Mr. Santosh Parab as an Independent Director with effect from May 24, 2016. |
| Feb 11, 2016 | Quarterly Results | - |
| Nov 09, 2015 | Quarterly Results | 1. Appointed Dr. Hira Sadhak- Ph.D in Industrial Finance, as Independent Director of the Company; 2. Appointed Ms. Aditi Bhatt as the Company Secretary of the Company. |
| Aug 14, 2015 | Quarterly Results | Mr. Vipul B. Thakkar appointed as the Chief Financial Officer (CFO) of the Company. |
| May 29, 2015 | Audited Results & Dividend | - |
| Feb 12, 2015 | Quarterly Results & Dividend | - |
| Oct 30, 2014 | Quarterly Results | - |
| Aug 11, 2014 | Quarterly Results | - |
| May 26, 2014 | Audited Results & Dividend | - |
| Feb 12, 2014 | Quarterly Results | - |
| Nov 13, 2013 | Quarterly Results | - |
| Aug 14, 2013 | Quarterly Results | - |
| May 28, 2013 | Audited Results & Dividend | - |
| Feb 13, 2013 | Quarterly Results & Dividend | - |
| Nov 09, 2012 | Quarterly Results | - |
| Aug 10, 2012 | Quarterly Results | - |
| May 30, 2012 | Audited Results & Dividend | - |
| Feb 06, 2012 | Quarterly Results | - |
| Nov 11, 2011 | Quarterly Results & Dividend | - |
| Jul 29, 2011 | Quarterly Results | - |
| May 30, 2011 | Audited Results & Dividend | - |
| Feb 02, 2011 | Quarterly Results | - |
| Nov 11, 2010 | Quarterly Results | - |
| Jul 28, 2010 | Quarterly Results | - |
| May 29, 2010 | Audited Results & Dividend | - |
| Jan 27, 2010 | Quarterly Results | - |
| Oct 26, 2009 | Quarterly Results | - |
| Jul 23, 2009 | Quarterly Results | - |
| Jun 26, 2009 | Audited Results | - |
| Jan 27, 2009 | Quarterly Results | - |
| Oct 24, 2008 | Quarterly Results | - |
| Jul 29, 2008 | Bonus Issue | To consider the declaration of Bonus Shares & the Board will decide the ratio and record date for the same. |
| Apr 28, 2008 | Interim Dividend | - |
| Jan 18, 2008 | Qtr Results, Stock Split & ESOP | - |
| Oct 12, 2007 | Employees Stock Option Plan | - |
| Jul 31, 2007 | Audited Results, Dividend & Qtr Results | - |
| Apr 30, 2007 | Quarterly Results | - |
| Mar 07, 2007 | To consider allotment of shares | To consider, allotment of shares on preferential basis to the promoter of the Company. |
| Jan 15, 2007 | Quarterly Results & Takeover | To consider take over of GVS Lab of Mr.S.N.Kamath. |
| Oct 30, 2006 | Quarterly Results | - |
| Jul 27, 2006 | Quarterly Results | - |
| Jun 27, 2006 | Accounts & Dividend | - |
| May 09, 2006 | Takeover of GVS Lab & Name change | To finalise the date of General Meeting of the members to consider: 1. The Take Over of GVS Labs; and 2. Change of Name of the Company. |
| May 02, 2006 | Change of Name of the Company | Take over of GVS Labs. |
| Apr 17, 2006 | Quarterly Results | - |
| Jan 23, 2006 | Quarterly Results | - |
| Oct 11, 2005 | Quarterly Results | - |
| Jul 25, 2005 | Bonus issue | - |
| Jul 14, 2005 | Quarterly Results & Accounts | - |
| Apr 21, 2005 | Quarterly Results | - |
| Jan 12, 2005 | Quarterly Results | - |
| Oct 26, 2004 | Quarterly Results | - |
| Jul 21, 2004 | Accounts & Quarterly Results | - |
| Jun 14, 2004 | General | - |
| May 18, 2004 | Others | Consider and take on record the proposed sale of management stake of the company by Skypak Group controlled by Mr. Dilip M. Kulkarni. |
| Apr 29, 2004 | Quarterly Results | - |
| Jan 21, 2004 | Quarterly Results | - |
| Oct 14, 2003 | Quarterly Results | - |
| Jul 24, 2003 | Accounts & Dividend & Quarterly Results | - |
| Apr 17, 2003 | Quarterly Results | - |
| Jan 10, 2003 | Quarterly Results | - |
| Oct 11, 2002 | Quarterly Results | - |
| Jul 04, 2002 | Accounts, Dividend & Quarterly Results | - |
| Apr 30, 2002 | Quarterly Results | - |
| Jan 26, 2002 | Quarterly Results | - |
| Oct 23, 2001 | Quarterly Results | - |
| Jul 09, 2001 | Accounts, Dividend & Quarterly Results | - |
| May 09, 2001 | Others | Allotment of equity shares to promoters. |
| Apr 27, 2001 | Quarterly Results | - |
| Feb 13, 2001 | Preferential Offer | Preferential allotment of shares to the promoters and Associates and increase in Authorised Capital. |
| Jan 17, 2001 | Quarterly Results | - |
| Oct 19, 2000 | Quarterly Results | - |
| Jul 18, 2000 | Quarterly Results | - |
| Jun 28, 2000 | Accounts | - |
| Jan 13, 2000 | Quarterly Results | - |
| Oct 15, 1999 | Quarterly Results | - |
| Jul 20, 1999 | Quarterly Results | - |
| Apr 20, 1999 | Half Yearly Results | - |
| Apr 19, 1999 | Quarterly Results | - |
| Jan 15, 1999 | Quarterly Results | - |
| Oct 15, 1998 | Quarterly Results | - |
| May 14, 1998 | Half Yearly Results | - |
| Nov 28, 1997 | Half Yearly Results | - |
| May 23, 1997 | Half Yearly Results. | - |
| Ex-Date | Bonus Ratio | Record Date |
|---|---|---|
| Sep 26, 2008 | 3:5 | 2008-09-30 |
| Sep 28, 2005 | 2:5 | 2005-10-01 |
01 Jul 2024
BLISS GVS PHARMA LTD. - 506197 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to Regulation 30 and Regulation 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed the copies of the newspaper notice in the interest of the shareholders regarding the intimation of 39th Annual General Meeting of the Company scheduled to be held on Thursday, July 25, 2024, at 11:00 a.m. (IST) through Video Conferencing ("VC")/Other Audio Visual Means ("OAVM"), published in the "The Economics Times, Free Press Journal, Maharshtra Times and Navshakti" newspaper on June 29, 2024.
28 Jun 2024
BLISS GVS PHARMA LTD. - 506197 - Closure of Trading Window
This is to inform you that pursuant to the Securities Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 (including any statutory modification(s) or re-enanctment(s) thereof, for the time being in force) and in accordance with the Code of Internal Procedures and Conduct for Regulating, Monitoring, and Reporting of Trading by Designated Persons, the Trading window for dealing in securities/shares of Bliss GVS Pharma Limited ("the Company") will remain closed for Insiders, Designated Persons and their immediate relatives of the Company with effect from Monday, July 01, 2024 till completion of 48 hours after the announcement of the Unaudited Financial Results of the Company for the quarter ended on June 30, 2024 generally made availabe to the public.
22 Jun 2024
BLISS GVS PHARMA LTD. - 506197 - Intimation Regarding The Appointment Of Additional Non-Executive Independent Director
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that, subject to approval of shareholders in ensuing 39th Annual General Meeting and based on recommendation of the Nomination and Remuneration Committee, the Board of Directors of the Company through circular resolution approved on June 22, 2024 have appointed Dr. Nandkumar Kashinath Chodankar (DIN:02736718) as a Additional Director in the category of Non-Executive Independent Director of the Company for a period of 5 yrs w.e.f. June 22, 2024. Please find enclosed the intimation is this regard.
21 Jun 2024
BLISS GVS PHARMA LTD. - 506197 - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Disclosure pursuant to Regulation 30 of the SEBI LODR Regulations 2015 is enclosed.
19 Jun 2024
BLISS GVS PHARMA LTD. - 506197 - Announcement under Regulation 30 (LODR)-Credit Rating
Pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and SEBI Circular No. SEBI/HO/CFD/CSD-PoD-1/P/CIR/2023/123 dated July 13, 2023, we would like to inform you that, CRISIL Ratings Limited vide its press releases dated June 19, 2024 bearing ref. no. RL/GDS2784/346423/BLR/0624/91401, has reaffirmed/assigned the ratings outstanding for the debt instruments/facilities of the Company, and the rating actions by CRISIL Ratings on the ratings as on date. Enclosed herewith intimation on the same.
10 Jun 2024
BLISS GVS PHARMA LTD. - 506197 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
We would like to inform you that the ESOP Allotment Committee of the Company at its meeting held on June 10, 2024, has approved the allotment of 1,45,000 equity shares of the face value of Re. 1/- each to the eligible employees who have exercised their stock options under Bliss GVS Pharma Limited-Employee Stock Option Plan 2019 ("Bliss GVS ESOP-2019").
29 May 2024
BLISS GVS PHARMA LTD. - 506197 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Pursuant to Regulation 24A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 201, please find enclosed herewith the Annual Secretarial Compliance Report of the Company for the financial year ended March 31, 2024.
15 May 2024
BLISS GVS PHARMA LTD. - 506197 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
We would like to inform you that the ESOP Allotment Committee of the Company at its meeting held on May 15, 2024, has approved the allotment of 46,750 equity shares of the face value of Re. 1/- each to the eligible employees who have exercised their stock options under Bliss GVS Pharma Limited-Employee Stock Option Plan 2019 (''Bliss GVS ESOP-2019'').
06 May 2024
BLISS GVS PHARMA LTD. - 506197 - Announcement under Regulation 30 (LODR)-Newspaper Publication
According to the provision of Regulation 47 of the SEBI (Listing Obligations and Disclsoure Requirements) Regulations, 2015, please find enclosed herewith the copies of the newspaper advertisement published regarding the extract of the statement of audited standalone and consolidated financial results for the quarter and year ended March 31, 2024 in "The Economic Times & The Free Press Journal" an English Daily and "Maharashtra Times & Navshakti" a Regionally Daily, on May 04, 2024.
02 May 2024
BLISS GVS PHARMA LTD. - 506197 - Grant Of Options Under Bliss GVS Pharma Limited - Employee Stock Options Plan 2019
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclsoure Requirements) Regulations, 2015 ("SEBI Listing Regulations") read with Para B of Part A of Schedule III of SEBI Listing Regulations, we would like to inform you that the Members of Nomination and Remuneration Committee of Bliss GVS Pharma Limited ("the Company") in its meeting held on today i.e. May 02, 2024 has granted 7,56,000 Stock Options under Bliss GVS Pharma Limited-Employee Stock Options Plan 2019 to the eligible employees of the Company.
